BLTE
Ticker
Belite Bio, Inc
BLTE · Healthcare · Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics…Belite Bio, Inc (BLTE), in the Healthcare sector, has 7 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 0 purchases and 7 sales. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Sep 8 and filed Sep 9. The most active filer was Hao-Yuan Chuang with 2 filings.
Add to watchlistFilings, ttm
7
0 buys · 7 sells
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$37.5M
estimated for Congress, as filed for insiders
Median delay
4d
execution to disclosure
Last traded
Sep 8
Filed Sep 9
ADViAverage daily dollar volume
$34.6M
market data
Share price · 12M
$169 (+137.4%)
Adjusted for splits and dividends.
Volume by month
Buys $0
Sells $37.5M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
HC
Hao-Yuan Chuang
Chief Financial Officer
2 filings
YL
Yu-Hsin Lin
Chief Executive Officer
2 filings
HS
Hendrik Peter Scholl
Chief Medical Officer
2 filings
WC
Wan-Shan Chen
Director
1 filing
Recent filings
Yu-Hsin LinSALE
Chief Executive Officer
$19.1M100,435 sh across 19 lots
Exec Sep 4
Filed Sep 9 · 7:39 PM ET Hao-Yuan ChuangSALE Chief Financial Officer $12.8M
67,395 sh across 19 lots
Exec Sep 4
Filed Sep 9 · 7:38 PM ET Hendrik Peter SchollSALE Chief Medical Officer $1.4M
9,808 sh across 3 lots
Exec Jun 18
Filed Jun 22 · 5:30 PM ET Hendrik Peter SchollSALE Chief Medical Officer $1.3M
8,910 sh across 5 lots
Exec Jun 16
Filed Jun 17 · 5:30 PM ET Hao-Yuan ChuangSALE Chief Financial Officer $1.1M
5,909 sh across 3 lots
Exec Apr 9
Filed Apr 13 · 5:30 PM ET Wan-Shan ChenSALE Director $198K
1,100 sh × $180.43
Exec Apr 9
Filed Apr 13 · 5:30 PM ET Yu-Hsin LinSALE Chief Executive Officer $1.6M
9,000 sh across 3 lots
Exec Apr 9
Filed Apr 13 · 5:30 PM ET